Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Dejaco, C; Schirmer, M; Duftner, C.
Classification Criteria and Methods for Assessment of Disease Activity in Polymyalgia Rheumatica
AKTUEL RHEUMATOL. 2014; 39(4): 241-244.
Doi: 10.1055/s-0034-1383586
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Dejaco Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The diagnosis of polymyalgia rheumatica is challenging. Several rheumatic and non-inflammatory conditions may mimic the disease and there is still no specific diagnostic marker available. In addition to the diagnostic and classification criteria published by Hunder, Healey and Bird that were all developed on the basis of clinical experience, ACR/EULAR proposed new classification criteria in 2012. These new criteria consider clinical factors, acute phase reactants and the rheumatoid factor/anti-cyclic citrullinierted peptide (CCP) antibodies as well as the result of ultrasound assessment of shoulders and hips. For the assessment of disease activity, the PMR Activity Score (PMR-AS) may be used combining the C-reactive protein, pain assessment by the patient, global assessment by the physician, morning stiffness and elevation of upper limb in a single measure. Patient reported outcome measures have not been developed for PMR. The value of imaging methods (such as ultrasound, magnetic resonance imaging, F-18-FDG-PET) for monitoring PMR patients has not been clarified so far.
- Find related publications in this database (Keywords)
-
polymyalgia rheumatica
-
diagnosis
-
classification criteria
-
disease activity